23andMe Holding Co (ME)
3.69
-0.13
(-3.40%)
USD |
NASDAQ |
Nov 15, 09:34
23andMe Cash and Short Term Investments (Quarterly): 169.97M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 169.97M |
| March 31, 2024 | 216.49M |
| December 31, 2023 | 242.42M |
| September 30, 2023 | 256.39M |
| June 30, 2023 | 314.35M |
| March 31, 2023 | 386.85M |
| December 31, 2022 | 432.80M |
| Date | Value |
|---|---|
| September 30, 2022 | 410.89M |
| June 30, 2022 | 479.40M |
| March 31, 2022 | 553.18M |
| December 31, 2021 | 586.20M |
| September 30, 2021 | 701.05M |
| June 30, 2021 | 769.94M |
| March 31, 2021 | 282.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
169.97M
Minimum
Jun 2024
769.94M
Maximum
Jun 2021
414.46M
Average
398.87M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| RadNet Inc | 741.68M |
| iSpecimen Inc | 1.752M |
| Delcath Systems Inc | 13.99M |
| CytoSorbents Corp | 5.685M |
| Progyny Inc | 262.19M |